Alpha-bisabolol for Onychomycosis Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

May 1, 2021

Conditions
Onychomycosis
Interventions
BIOLOGICAL

Drug recommended by the Brazilian Society of Dermatology

Using a drug recommended by the Brazilian Society of Dermatology, twice a day.

COMBINATION_PRODUCT

Alpha bisabolol product and laser

Using alpha bisabolol-based product associated with low-level laser therapy. Alpha bisabolol-based product will be used twice a day, and laser therapy used once every fortnight.

BIOLOGICAL

Alpha bisabolol product

Using alpha bisabolol-based product twice a day

Trial Locations (1)

37550-000

Vale do Sapucaí University, Pouso Alegre

All Listed Sponsors
lead

Universidade do Vale do Sapucai

OTHER

NCT04940520 - Alpha-bisabolol for Onychomycosis Treatment | Biotech Hunter | Biotech Hunter